Involved in N-glycan biogenesis, conserved eukaryotic protein.. Localization: ER (by homology)
Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 8 |
NetGPI | no | yes: 0, no: 8 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 4 |
GO:0110165 | cellular anatomical entity | 1 | 4 |
Related structures:
AlphaFold database: E9B0G5
Term | Name | Level | Count |
---|---|---|---|
GO:0006486 | protein glycosylation | 4 | 6 |
GO:0006487 | protein N-linked glycosylation | 5 | 6 |
GO:0006807 | nitrogen compound metabolic process | 2 | 6 |
GO:0008152 | metabolic process | 1 | 9 |
GO:0019538 | protein metabolic process | 3 | 6 |
GO:0036211 | protein modification process | 4 | 6 |
GO:0043170 | macromolecule metabolic process | 3 | 6 |
GO:0043412 | macromolecule modification | 4 | 6 |
GO:0043413 | macromolecule glycosylation | 3 | 6 |
GO:0044238 | primary metabolic process | 2 | 9 |
GO:0070085 | glycosylation | 2 | 6 |
GO:0071704 | organic substance metabolic process | 2 | 9 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 6 |
GO:0006629 | lipid metabolic process | 3 | 1 |
GO:0006793 | phosphorus metabolic process | 3 | 1 |
GO:0006796 | phosphate-containing compound metabolic process | 4 | 1 |
GO:0009987 | cellular process | 1 | 1 |
GO:0016311 | dephosphorylation | 5 | 1 |
GO:0030258 | lipid modification | 4 | 1 |
GO:0044237 | cellular metabolic process | 2 | 1 |
GO:0044255 | cellular lipid metabolic process | 3 | 1 |
GO:0046839 | phospholipid dephosphorylation | 5 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 9 |
GO:0016462 | pyrophosphatase activity | 5 | 6 |
GO:0016787 | hydrolase activity | 2 | 9 |
GO:0016817 | hydrolase activity, acting on acid anhydrides | 3 | 6 |
GO:0016818 | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | 4 | 6 |
GO:0047874 | dolichyldiphosphatase activity | 6 | 6 |
GO:0016788 | hydrolase activity, acting on ester bonds | 3 | 4 |
GO:0016791 | phosphatase activity | 5 | 4 |
GO:0042392 | sphingosine-1-phosphate phosphatase activity | 7 | 1 |
GO:0042577 | lipid phosphatase activity | 6 | 1 |
GO:0042578 | phosphoric ester hydrolase activity | 4 | 4 |
GO:0008195 | phosphatidate phosphatase activity | 6 | 3 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 141 | 143 | PF00675 | 0.269 |
CLV_NRD_NRD_1 | 147 | 149 | PF00675 | 0.283 |
CLV_NRD_NRD_1 | 153 | 155 | PF00675 | 0.289 |
CLV_NRD_NRD_1 | 79 | 81 | PF00675 | 0.378 |
CLV_PCSK_FUR_1 | 77 | 81 | PF00082 | 0.391 |
CLV_PCSK_KEX2_1 | 141 | 143 | PF00082 | 0.293 |
CLV_PCSK_KEX2_1 | 147 | 149 | PF00082 | 0.305 |
CLV_PCSK_KEX2_1 | 153 | 155 | PF00082 | 0.309 |
CLV_PCSK_KEX2_1 | 79 | 81 | PF00082 | 0.378 |
CLV_PCSK_SKI1_1 | 227 | 231 | PF00082 | 0.373 |
DEG_Nend_UBRbox_1 | 1 | 4 | PF02207 | 0.339 |
DOC_CYCLIN_yClb5_NLxxxL_5 | 81 | 90 | PF00134 | 0.532 |
DOC_MAPK_gen_1 | 77 | 86 | PF00069 | 0.538 |
DOC_MAPK_MEF2A_6 | 235 | 242 | PF00069 | 0.551 |
DOC_MAPK_MEF2A_6 | 79 | 88 | PF00069 | 0.504 |
DOC_PP1_RVXF_1 | 225 | 232 | PF00149 | 0.454 |
DOC_USP7_MATH_1 | 165 | 169 | PF00917 | 0.515 |
DOC_USP7_MATH_1 | 22 | 26 | PF00917 | 0.534 |
DOC_WW_Pin1_4 | 103 | 108 | PF00397 | 0.298 |
DOC_WW_Pin1_4 | 172 | 177 | PF00397 | 0.570 |
DOC_WW_Pin1_4 | 24 | 29 | PF00397 | 0.456 |
LIG_14-3-3_CanoR_1 | 147 | 156 | PF00244 | 0.504 |
LIG_14-3-3_CanoR_1 | 227 | 232 | PF00244 | 0.577 |
LIG_Actin_WH2_2 | 85 | 103 | PF00022 | 0.465 |
LIG_BRCT_BRCA1_1 | 50 | 54 | PF00533 | 0.341 |
LIG_EH1_1 | 53 | 61 | PF00400 | 0.387 |
LIG_eIF4E_1 | 178 | 184 | PF01652 | 0.465 |
LIG_eIF4E_1 | 44 | 50 | PF01652 | 0.396 |
LIG_FHA_1 | 186 | 192 | PF00498 | 0.417 |
LIG_FHA_1 | 220 | 226 | PF00498 | 0.368 |
LIG_FHA_1 | 246 | 252 | PF00498 | 0.572 |
LIG_FHA_1 | 38 | 44 | PF00498 | 0.417 |
LIG_FHA_2 | 18 | 24 | PF00498 | 0.544 |
LIG_FHA_2 | 25 | 31 | PF00498 | 0.400 |
LIG_GBD_Chelix_1 | 181 | 189 | PF00786 | 0.290 |
LIG_LIR_Apic_2 | 119 | 125 | PF02991 | 0.315 |
LIG_LIR_Gen_1 | 175 | 186 | PF02991 | 0.522 |
LIG_LIR_Nem_3 | 175 | 181 | PF02991 | 0.497 |
LIG_LIR_Nem_3 | 188 | 193 | PF02991 | 0.239 |
LIG_LYPXL_SIV_4 | 177 | 185 | PF13949 | 0.515 |
LIG_NRBOX | 179 | 185 | PF00104 | 0.465 |
LIG_Pex14_2 | 131 | 135 | PF04695 | 0.330 |
LIG_Pex14_2 | 186 | 190 | PF04695 | 0.368 |
LIG_RPA_C_Fungi | 7 | 19 | PF08784 | 0.676 |
LIG_SH2_CRK | 118 | 122 | PF00017 | 0.361 |
LIG_SH2_CRK | 178 | 182 | PF00017 | 0.429 |
LIG_SH2_CRK | 200 | 204 | PF00017 | 0.352 |
LIG_SH2_NCK_1 | 118 | 122 | PF00017 | 0.387 |
LIG_SH2_NCK_1 | 178 | 182 | PF00017 | 0.465 |
LIG_SH2_STAP1 | 118 | 122 | PF00017 | 0.387 |
LIG_SH2_STAP1 | 178 | 182 | PF00017 | 0.401 |
LIG_SH2_STAT5 | 118 | 121 | PF00017 | 0.363 |
LIG_SH2_STAT5 | 138 | 141 | PF00017 | 0.411 |
LIG_SH2_STAT5 | 89 | 92 | PF00017 | 0.383 |
LIG_SH3_3 | 101 | 107 | PF00018 | 0.344 |
LIG_SH3_3 | 25 | 31 | PF00018 | 0.698 |
LIG_TYR_ITIM | 116 | 121 | PF00017 | 0.242 |
LIG_TYR_ITIM | 87 | 92 | PF00017 | 0.411 |
MOD_CDK_SPK_2 | 103 | 108 | PF00069 | 0.363 |
MOD_CK2_1 | 17 | 23 | PF00069 | 0.703 |
MOD_CK2_1 | 24 | 30 | PF00069 | 0.519 |
MOD_CMANNOS | 34 | 37 | PF00535 | 0.473 |
MOD_GlcNHglycan | 163 | 166 | PF01048 | 0.407 |
MOD_GlcNHglycan | 167 | 170 | PF01048 | 0.451 |
MOD_GlcNHglycan | 72 | 75 | PF01048 | 0.427 |
MOD_GSK3_1 | 161 | 168 | PF00069 | 0.446 |
MOD_GSK3_1 | 17 | 24 | PF00069 | 0.706 |
MOD_GSK3_1 | 33 | 40 | PF00069 | 0.397 |
MOD_NEK2_1 | 171 | 176 | PF00069 | 0.400 |
MOD_NEK2_1 | 185 | 190 | PF00069 | 0.265 |
MOD_NEK2_1 | 218 | 223 | PF00069 | 0.411 |
MOD_NEK2_1 | 242 | 247 | PF00069 | 0.512 |
MOD_NEK2_1 | 54 | 59 | PF00069 | 0.363 |
MOD_NEK2_1 | 90 | 95 | PF00069 | 0.411 |
MOD_NEK2_2 | 117 | 122 | PF00069 | 0.174 |
MOD_NEK2_2 | 133 | 138 | PF00069 | 0.465 |
MOD_PKA_2 | 161 | 167 | PF00069 | 0.259 |
MOD_Plk_1 | 22 | 28 | PF00069 | 0.529 |
MOD_Plk_4 | 117 | 123 | PF00069 | 0.290 |
MOD_Plk_4 | 185 | 191 | PF00069 | 0.376 |
MOD_Plk_4 | 227 | 233 | PF00069 | 0.380 |
MOD_Plk_4 | 242 | 248 | PF00069 | 0.501 |
MOD_Plk_4 | 55 | 61 | PF00069 | 0.355 |
MOD_ProDKin_1 | 103 | 109 | PF00069 | 0.363 |
MOD_ProDKin_1 | 172 | 178 | PF00069 | 0.464 |
MOD_ProDKin_1 | 24 | 30 | PF00069 | 0.578 |
TRG_ENDOCYTIC_2 | 118 | 121 | PF00928 | 0.389 |
TRG_ENDOCYTIC_2 | 156 | 159 | PF00928 | 0.290 |
TRG_ENDOCYTIC_2 | 178 | 181 | PF00928 | 0.364 |
TRG_ENDOCYTIC_2 | 200 | 203 | PF00928 | 0.352 |
TRG_ENDOCYTIC_2 | 89 | 92 | PF00928 | 0.411 |
TRG_ER_diArg_1 | 140 | 142 | PF00400 | 0.354 |
TRG_ER_diArg_1 | 147 | 150 | PF00400 | 0.372 |
TRG_ER_diArg_1 | 79 | 81 | PF00400 | 0.475 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1IGH8 | Leptomonas seymouri | 61% | 94% |
A0A1X0P264 | Trypanosomatidae | 34% | 100% |
A0A3S7X373 | Leishmania donovani | 90% | 93% |
A0A422NMI8 | Trypanosoma rangeli | 34% | 100% |
A4HHZ1 | Leishmania braziliensis | 80% | 100% |
A4I568 | Leishmania infantum | 91% | 93% |
B0CM95 | Papio anubis | 32% | 100% |
B0KWE9 | Callithrix jacchus | 32% | 100% |
B1MTH4 | Plecturocebus moloch | 32% | 100% |
B2KI79 | Rhinolophus ferrumequinum | 32% | 100% |
C9ZQJ4 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 30% | 100% |
P53223 | Saccharomyces cerevisiae (strain ATCC 204508 / S288c) | 29% | 100% |
Q4Q7R8 | Leishmania major | 88% | 100% |
Q86IX2 | Dictyostelium discoideum | 27% | 100% |
Q86YN1 | Homo sapiens | 32% | 100% |
Q9JMF7 | Mus musculus | 31% | 100% |